Dual sodium-glucose cotransporter (SGLT) 1/2 versus pure SGLT2 inhibitors: two distinct drug categories or one class with multiple faces?

Koufakis, T; Doumas, M; Zebekakis, P; Kotsa, K

Kotsa, K (通讯作者)，Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Med Sch, Div Endocrinol,Dept Internal Med 1, 1 St Kiriakidi St, Thessaloniki 54636, Greece.;Kotsa, K (通讯作者)，Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Med Sch, Metab & Diabet Ctr,Dept Internal Med 1, 1 St Kiriakidi St, Thessaloniki 54636, Greece.

EXPERT OPINION ON PHARMACOTHERAPY, 2022; 23 (13): 1497

Abstract

Introduction According to their selectivity for sodium-glucose cotransporters (SGLT) 1 and 2, gliflozins could be subdivided into two additional categ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索